Latest news
Alvotech (ALVO) Could Be 72% Undervalued Following FDA Inspection Closure - simplywall.stsimplywall.st · Wed, 05 Aug 2026 09:00:33 GMTAlvotech (ALVO) Stock Analysis: Exploring a Potential 51.72% Upside in the Biosimilars Market - DirectorsTalk InterviewsDirectorsTalk Interviews · Tue, 04 Aug 2026 09:16:03 GMTAlvotech (NASDAQ:ALVO) Shares Down 6.7% - Time to Sell? - MarketBeatMarketBeat · Mon, 03 Aug 2026 17:10:29 GMTAlvotech (ALVO) Is Up 34.6% After FDA Clears Reykjavik Plant And BLAs Advance - Has The Bull Case Changed? - webull.comwebull.com · Mon, 03 Aug 2026 08:56:51 GMTNovo misses, AstraZeneca holds steady, Alvotech clears FDA – the Nordic Pulse | 2026:31 - BiostockBiostock · Mon, 03 Aug 2026 07:00:00 GMTAlvotech (NASDAQ:ALVO) Given Consensus Rating of "Hold" by Brokerages - MarketBeatMarketBeat · Thu, 30 Jul 2026 08:47:46 GMTAlvotech Shares Rise After Wrapping FDA Facility Inspection - MoomooMoomoo · Wed, 29 Jul 2026 16:24:00 GMTUS FDA Closes Inspection of Alvotech's Manufacturing Facility in Iceland - MoomooMoomoo · Wed, 29 Jul 2026 14:44:53 GMT